TRIFERIC (FERRIC PYROPHOSPHATE CITRATE) — FDA Approval NDA206317 (ROCKWELL MEDICAL INC)
TRIFERIC (FERRIC PYROPHOSPHATE CITRATE) — FDA Approval NDA206317 (ROCKWELL MEDICAL INC) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: TRIFERIC; Active ingredients: FERRIC PYROPHOSPHATE CITRATE; Application number: NDA206317.
| Brand name | TRIFERIC |
|---|---|
| Active ingredients | FERRIC PYROPHOSPHATE CITRATE |
| Application number | NDA206317 |
| Sponsor | ROCKWELL MEDICAL INC |
| Dosage form | SOLUTION |
| Route | INTRAVENOUS |
| Marketing status | Discontinued |
| Products in application | 2 |
| First approval date | 20150123 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →